• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol. 2015 Apr 3:ajplung.00078.2015. doi: 10.1152/ajplung.00078.2015. [Epub ahead of print]
[h=1]TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.[/h] Woods PS[SUP]1[/SUP], Tazi MF[SUP]1[/SUP], Chesarino NM[SUP]1[/SUP], Amer AO[SUP]1[/SUP], Davis IC[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] As the 8[SUP]th[/SUP] leading cause of annual mortality in the USA, influenza A viruses are a major public health concern. In 20% of patients, severe influenza progresses to acute lung injury (ALI). However, pathophysiologic mechanisms underlying ALI development are poorly-defined. We reported that, unlike wild-type (WT) C57BL/6 controls, influenza A virus-infected mice that are heterozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator (HETs) did not develop ALI. This effect was associated with higher IL-6 and alveolar macrophages (AMs) at 6 days post-infection (d.p.i.) in HET bronchoalveolar lavage fluid (BALF). In the current study, we found that HET AMs were an important source of IL-6 at 6 d.p.i. Infection also induced TGF-β production by HET but not WT mice at 2 d.p.i. TGF-β neutralization at 2 d.p.i. (TGF-N) significantly reduced BALF IL-6 in HETs at 6 d.p.i. Neither TGF-N nor IL-6 neutralization at 4 d.p.i. (IL-6-N) altered post-infection weight loss or viral replication in either mouse strain. However, both treatments increased influenza A virus-induced hypoxemia, pulmonary edema, and lung dysfunction in HETs to WT levels at 6 d.p.i. TGF-N and IL-6-N did not affect BALF AM and neutrophil numbers, but attenuated the CXCL-1/KC response in both strains, and reduced IFN-γ production in WT mice. Finally, bone marrow transfer experiments showed that HET stromal and myeloid cells are both required for protection from ALI in HETs. These findings indicate that TGF-β-dependent production of IL-6 by AMs later in infection prevents ALI development in influenza A virus-infected HET mice.
Copyright ? 2015, American Journal of Physiology - Lung Cellular and Molecular Physiology.


[h=4]KEYWORDS:[/h] Acute lung injury; CFTR; IL-6; Influenza; Transforming growth factor-beta

PMID: 25840995 [PubMed - as supplied by publisher]
 
Back
Top Bottom